UK markets close in 1 hour 7 minutes

Soligenix, Inc. (0A6I.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
0.4042-0.0156 (-3.72%)
As of 05:58PM BST. Market open.
Full screen
Previous close0.4198
Open0.0000
Bid0.0000 x N/A
Ask0.0000 x N/A
Day's range0.0000 - 0.0000
52-week range
Volume7,410
Avg. volume8,171
Market capN/A
Beta (5Y monthly)1.93
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Benzinga

    Why Is Penny Stock Soligenix Trading Higher On Monday?

    On Monday, Soligenix Inc (NASDAQ:SNGX) received an FDA orphan drug designation for the active ingredient in MarVax, the subunit protein vaccine of recombinantly expressed Marburg marburgvirus (MARV) glycoprotein, for the prevention and post-exposure prophylaxis against MARV infection. In addition to providing a seven-year term of market exclusivity upon final FDA approval, orphan drug designation also positions Soligenix to be able to leverage a wide range of financial and regulatory benefits, i

  • Simply Wall St.

    Here's Why We Think Soligenix, Inc.'s (NASDAQ:SNGX) CEO Compensation Looks Fair

    Key Insights Soligenix will host its Annual General Meeting on 15th of December Total pay for CEO Christopher Schaber...